News & Updates
Filter by Specialty:
Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
In patients with neovascular age-related macular degeneration (nAMD) who switched to brolucizumab treatment, those with shorter treatment interval before switching are more likely to have successful injection interval extension, as shown in a study.
Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
31 Jul 2023
IMDC score, metastatic sites predict survival in mRCC patients undergoing surveillance
Surveillance of favourable-risk patients with metastatic renal cell carcinoma (mRCC) using risk stratification based on the International mRCC Database Consortium (IMDC) and number of metastatic sites may be done following cytoreductive nephrectomy without initiating systemic therapy, suggests a recent study.
IMDC score, metastatic sites predict survival in mRCC patients undergoing surveillance
30 Jul 2023
Financial toxicity in prostate cancer means less spending on basic goods, leisure
Patients with metastatic prostate cancer who report high financial toxicity tend to spend less on basic goods and leisure activity and use their savings to pay for care, according to the results of a cross-sectional study.
